Haoxi Health Technology (HAO)
Short-video advertising and media-buying services for Chinese healthcare advertisers.
Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split
BEIJING, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; "we" or the "Company"), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0000001 per share (the "Class A Ordinary Shares") and Class B ordinary shares, par value $0.0000001 per share (the "Class B Ordinary Shares"), at a ratio of 1-for-20. Our Class A Ordinary Shares will begin trading on a reverse share split-adjusted basis at the opening of The Nasdaq Capital Market ("Nasdaq") on August 14, 2026.
Haoxi Health Technology Limited (NASDAQ:HAO) Short Interest Up 810.7% in July
Haoxi Health Technology Limited (NASDAQ: HAO - Get Free Report) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 544,897 shares, an increase of 810.7% from the June 30th total of 59,833 shares. Approximately 7.4% of the shares of the stock
Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO) (the "Company"), a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients.
Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO) (the "Company"), a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients.
Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering
BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 10,000,000 of the Company's Class A Ordinary Shares, par value $0.32 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.40 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.33 per share.
Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split
BEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; “we” or the “Company”), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0025 per share (the “Class A Ordinary Shares”) and Class B ordinary shares, par value $0.0025 per share (the “Class B Ordinary Shares”), at a ratio of 1-for-128.
Univest Securities, LLC Announces Closing of $6.5 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
New York, May 12, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of $6.5 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO)(the “Company”), a Beijing-headquartered technology company engaged in the provision of online marketing solutions for healthcare industry clients, with a focus on short-form video and news feed advertising across major Chinese digital platforms.
Haoxi Health Technology Ltd Announces $6.5 Million Registered Direct Offering
BEIJING, May 11, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”) today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5 million of the Company's securities, including 9,000,000 Class A ordinary shares, par value $0.0025 per share (the “Shares”) and 16,999,998 pre-funded warrants, at a purchase price of $0.25 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0026 per share.
Haoxi Health Technology (NASDAQ:HAO) Shares Up 0.1% – Still a Buy?
Shares of Haoxi Health Technology Limited (NASDAQ: HAO - Get Free Report) shot up 0.1% during mid-day trading on Friday. The stock traded as high as $1.15 and last traded at $1.1010. 6,899 shares traded hands during trading, a decline of 50% from the average session volume of 13,834 shares. The stock had previously closed
Haoxi Health Technology (NASDAQ:HAO) Trading Down 0.9% – Time to Sell?
Haoxi Health Technology Limited (NASDAQ: HAO - Get Free Report)'s stock price dropped 0.9% during trading on Wednesday. The company traded as low as $1.12 and last traded at $1.15. Approximately 321 shares changed hands during trading, a decline of 94% from the average daily volume of 5,789 shares. The stock had previously closed at
Haoxi Health Technology (NASDAQ:HAO) vs. Direct Digital (NASDAQ:DRCT) Head to Head Contrast
Direct Digital (NASDAQ: DRCT - Get Free Report) and Haoxi Health Technology (NASDAQ: HAO - Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, valuation, analyst recommendations, risk and institutional ownership. Valuation and Earnings This table
Haoxi Health Technology Limited Launches Customized Livestreaming Agency Strategy
BEIJING, April 21, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, announced that Beijing Haoxi Digital Technology Co., Ltd. (“Haoxi Beijing”), a wholly-owned subsidiary of the Company, has launched its customized livestreaming agency strategy and is progressing partnership discussions on personalized livestreaming agency services with several long-term clients of medical aesthetics, marking a new strategic step in the Company's business development roadmap.
Haoxi Health Technology Limited Announces 1-for-25 Reverse Share Split
BEIJING, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it has resolved to effect a reverse share split of the Company's ordinary shares, with the split ratio set at 1-for-25 (the “Reverse Share Split”). The Reverse Share Split was approved by the Company's shareholders at an annual general meeting of shareholders held on January 10, 2025. The Company's Class A ordinary shares will begin trading on an adjusted basis on the Nasdaq Capital Market, reflecting the Reverse Share Split, when the market opens on January 27, 2025, under the existing ticker symbol “HAO.” The new CUSIP number for the Company's Class A ordinary shares will be G4290F118.
Haoxi Health Technology Limited Awarded a RMB30 Milllion Framework Contract to Provide Digital Advertising Services for Tengyuan Media Advertising Co., Ltd.
BEIJING, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced the Company's wholly owned subsidiary Beijing Haoxi Digital Technology Co., Ltd. (“Beijing Haoxi”) was awarded a Recharge Service Framework Contract (the “Contract”) to provide comprehensive digital advertising services with a budget of RMB30 million for Tengyuan Media Advertising Co., Ltd. (“Tengyuan") and its clients.
Haoxi Health Technology Limited Reports Financial Results for Fiscal Year Ended June 30, 2024
BEIJING, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today reported its financial results for the fiscal year ended June 30, 2024.
Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue Growth
BEIJING, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced preliminary unaudited financial results for the fiscal year ended June 30, 2024 (“FY24”).
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended December 31, 2023
BEIJING, May 31, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today reported its unaudited financial results for the six months ended December 31, 2023.
Haoxi Health Technology Limited Enters into Rebate Agreement with Clients on Advertising Placement Campaign
BEIJING, May 07, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that Beijing Haoxi Digital Technology Co., Ltd. (“Haoxi Beijing”), a wholly-owned subsidiary of the Company, entered into a bidding data promotion rebate agreement (the “Rebate Agreement”) on April 29, 2024 with Jinan Yanling Biotechnology Co., Ltd. (“Yanling”) and its subsidiaries and affiliated companies (together, the “Clients”).
Haoxi Health Technology Limited Enters into Advertising Placement Service Framework Contract
BEIJING, May 03, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that Beijing Haoxi Digital Technology Co., Ltd. (“Haoxi Beijing”), a wholly-owned subsidiary of the Company, entered into a Framework Contract for Cooperation on Information Placement on Media Platforms (the “Framework Contract”) on April 28, 2024 with Wuhan Yiya Simei Dental Clinic Co., Ltd. (“Yiya Dental”), a regional dentistry chain in China. This partnership underscores the Company's capabilities in delivering internet marketing solutions.
Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio This Quarter - AMC Enter Hldgs (NYSE:AMC), Haoxi Health Technology (NASDAQ:HAO)
The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.